---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-019977"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-01-27T23:59:59+00:00"
generated_at: "2026-06-27T14:47:08.108632+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CytoDyn terminates CEO Nader Pourhassan; CFO Migliarese named interim president

## Summary
- Board terminated CEO Nader Z. Pourhassan on Jan 24, 2022; he also resigned from the board.
- Antonio Migliarese, current CFO, elected interim president; a committee will search for a permanent CEO.
- Tanya Durkee Urbach elected Chairman of the Board; Scott Kelly remains CMO and director.

## SEC filing metadata
- accession: 0001193125-22-019977
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-01-27T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/d276339d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-019977
- JSON: https://secwatch.observer/filing/0001193125-22-019977.json
- Plain text: https://secwatch.observer/filing/0001193125-22-019977.txt

## Key facts
- Executive change
  Nader Z. Pourhassan was terminated as President and Chief Executive Officer at CytoDyn Inc..
  - Action: terminated
  - Role: President and Chief Executive Officer
  source text: On January 24, 2022, the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”) terminated the employment of the Company’s President and Chief Executive Officer, Nader Z. Pourhassan, Ph.D., and removed him as an officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm
- Executive change
  Antonio Migliarese was elected as interim President at CytoDyn Inc..
  - Action: elected
  - Role: interim President
  source text: Also on January 24, 2022, the Board elected Antonio Migliarese interim President of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000119312522019977/0001193125-22-019977-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.